000 | 01863 a2200541 4500 | ||
---|---|---|---|
005 | 20250515211922.0 | ||
264 | 0 | _c20100920 | |
008 | 201009s 0 0 eng d | ||
022 | _a1533-4023 | ||
024 | 7 |
_a10.1097/FJC.0b013e3181d9f5f4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYen, Chia-Hung | |
245 | 0 | 0 |
_aSildenafil limits monocrotaline-induced pulmonary hypertension in rats through suppression of pulmonary vascular remodeling. _h[electronic resource] |
260 |
_bJournal of cardiovascular pharmacology _cJun 2010 |
||
300 |
_a574-84 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aArterioles _xdrug effects |
650 | 0 | 4 |
_aBlood Vessels _xmetabolism |
650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
650 | 0 | 4 |
_aConnexin 43 _xmetabolism |
650 | 0 | 4 |
_aHypertension _xmetabolism |
650 | 0 | 4 |
_aHypertension, Pulmonary _xchemically induced |
650 | 0 | 4 |
_aLung _xblood supply |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMonocrotaline _xadverse effects |
650 | 0 | 4 |
_aNitric Oxide Synthase Type III _xmetabolism |
650 | 0 | 4 | _aPiperazines |
650 | 0 | 4 | _aPurines |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aSildenafil Citrate |
650 | 0 | 4 | _aSulfones |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xadverse effects |
650 | 0 | 4 |
_aVentricular Myosins _xadverse effects |
700 | 1 | _aLeu, Steve | |
700 | 1 | _aLin, Yu-Chun | |
700 | 1 | _aKao, Ying-Hsien | |
700 | 1 | _aChang, Li-Teh | |
700 | 1 | _aChua, Sarah | |
700 | 1 | _aFu, Morgan | |
700 | 1 | _aWu, Chiung-Jen | |
700 | 1 | _aSun, Cheuk-Kwan | |
700 | 1 | _aYip, Hon-Kan | |
773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 55 _gno. 6 _gp. 574-84 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/FJC.0b013e3181d9f5f4 _zAvailable from publisher's website |
999 |
_c19590711 _d19590711 |